Literature DB >> 3440386

Recruitment in the Cooperative Study of Sickle Cell Disease (CSSCD).

M Gaston, J Smith, D Gallagher, Z Flournoy-Gill, S West, R Bellevue, M Farber, R Grover, M Koshy, A K Ritchey.   

Abstract

The Cooperative Study of Sickle Cell Disease (CSSCD) is a multiinstitutional investigation of the natural history of clinical course of sickle cell disease from birth through adulthood. The study is not a trial; rather, it involves data collection at 23 institutions in a uniform, standardized fashion on 3800 patients. Recruitment aspects that were addressed include issues related to recruitment of different age groups, ranging from newborns to pregnant women to patients over 50 years of age; the need to include mildly affected patients to ensure that the study would not reflect only a severe hospital-based population; recruitment from rural populations; and the need to screen and enter a newborn population at birth. The recruitment goal of entering 3200 patients, including 2100 patients with SS hemoglobinopathy, over a 24-month period was accomplished after 27 months.

Entities:  

Mesh:

Year:  1987        PMID: 3440386     DOI: 10.1016/0197-2456(87)90016-x

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  23 in total

1.  Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia.

Authors:  Paola Sebastiani; Marco F Ramoni; Vikki Nolan; Clinton T Baldwin; Martin H Steinberg
Journal:  Nat Genet       Date:  2005-03-20       Impact factor: 38.330

2.  Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis.

Authors:  Clinton Baldwin; Vikki G Nolan; Diego F Wyszynski; Qian-Li Ma; Paola Sebastiani; Stephen H Embury; Alice Bisbee; John Farrell; Lindsay Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

3.  Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway.

Authors:  Vikki G Nolan; Adeboye Adewoye; Clinton Baldwin; Ling Wang; Qianli Ma; Diego F Wyszynski; John J Farrell; Paola Sebastiani; Lindsay A Farrer; Martin H Steinberg
Journal:  Br J Haematol       Date:  2006-06       Impact factor: 6.998

Review 4.  The search for genetic modifiers of disease severity in the β-hemoglobinopathies.

Authors:  Guillaume Lettre
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

5.  Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study.

Authors:  Jane S Hankins; Russell E Ware; Zora R Rogers; Lynn W Wynn; Peter A Lane; J Paul Scott; Winfred C Wang
Journal:  Blood       Date:  2005-10-01       Impact factor: 22.113

6.  Age is a predictor of a small decrease in lung function in children with sickle cell anemia.

Authors:  Shaina M Willen; Robyn Cohen; Mark Rodeghier; Fenella Kirkham; Susan S Redline; Carol Rosen; Jane Kirkby; Michael R DeBaun
Journal:  Am J Hematol       Date:  2018-01-25       Impact factor: 10.047

7.  Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia.

Authors:  Jonathan M Flanagan; Vivien Sheehan; Heidi Linder; Thad A Howard; Yong-Dong Wang; Carolyn C Hoppe; Banu Aygun; Robert J Adams; Geoffrey A Neale; Russell E Ware
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

8.  Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients.

Authors:  Geneviève Galarneau; Sean Coady; Melanie E Garrett; Neal Jeffries; Mona Puggal; Dina Paltoo; Karen Soldano; Antonio Guasch; Allison E Ashley-Koch; Marilyn J Telen; Abdullah Kutlar; Guillaume Lettre; George J Papanicolaou
Journal:  Blood       Date:  2013-05-29       Impact factor: 22.113

9.  Factors predicting future ACS episodes in children with sickle cell anemia.

Authors:  Michael R DeBaun; Mark Rodeghier; Robyn Cohen; Fenella J Kirkham; Carol L Rosen; Irene Roberts; Ben Cooper; Janet Stocks; Olu Wilkey; Baba Inusa; John O Warner; Robert C Strunk
Journal:  Am J Hematol       Date:  2014-08-27       Impact factor: 10.047

10.  Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.

Authors:  Li Liu; Alexander Pertsemlidis; Liang-Hao Ding; Michael D Story; Martin H Steinberg; Paola Sebastiani; Carolyn Hoppe; Samir K Ballas; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.